Axa S.A. Reduces Holdings in Ceridian HCM Holding Inc. (NYSE:CDAY)

Axa S.A. trimmed its stake in Ceridian HCM Holding Inc. (NYSE:CDAYGet Rating) by 11.0% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 33,850 shares of the company’s stock after selling 4,189 shares during the period. Axa S.A.’s holdings in Ceridian HCM were worth $1,891,000 at the end of the most recent quarter.

Other hedge funds have also recently modified their holdings of the company. Quadrant Capital Group LLC grew its position in shares of Ceridian HCM by 114.8% in the 2nd quarter. Quadrant Capital Group LLC now owns 844 shares of the company’s stock valued at $40,000 after buying an additional 451 shares during the last quarter. Advisors Asset Management Inc. acquired a new stake in Ceridian HCM during the 1st quarter worth $41,000. Allworth Financial LP boosted its stake in Ceridian HCM by 258.2% during the 3rd quarter. Allworth Financial LP now owns 978 shares of the company’s stock worth $55,000 after purchasing an additional 705 shares during the period. Wahed Invest LLC acquired a new stake in Ceridian HCM during the 2nd quarter worth $69,000. Finally, Federated Hermes Inc. acquired a new stake in Ceridian HCM during the 2nd quarter worth $70,000.

Wall Street Analyst Weigh In

CDAY has been the subject of a number of recent research reports. BMO Capital Markets increased their price target on shares of Ceridian HCM from $73.00 to $86.00 and gave the stock an “outperform” rating in a research note on Thursday, February 9th. Wells Fargo & Company increased their price target on shares of Ceridian HCM from $65.00 to $75.00 and gave the stock an “equal weight” rating in a research note on Thursday, February 9th. Cowen increased their price target on shares of Ceridian HCM from $77.00 to $87.00 and gave the stock an “outperform” rating in a research note on Thursday, February 9th. Mizuho raised their target price on shares of Ceridian HCM from $80.00 to $95.00 and gave the stock a “buy” rating in a research note on Thursday, February 9th. Finally, Credit Suisse Group raised their target price on shares of Ceridian HCM from $90.00 to $105.00 and gave the stock an “outperform” rating in a research note on Thursday, February 9th. Five equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $79.64.

Insider Buying and Selling at Ceridian HCM

In other Ceridian HCM news, COO Christopher R. Armstrong sold 3,902 shares of the firm’s stock in a transaction dated Thursday, February 9th. The shares were sold at an average price of $77.50, for a total transaction of $302,405.00. Following the completion of the transaction, the chief operating officer now directly owns 96,575 shares in the company, valued at approximately $7,484,562.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, CEO Leagh Erin Turner sold 6,500 shares of Ceridian HCM stock in a transaction dated Monday, January 9th. The shares were sold at an average price of $61.52, for a total transaction of $399,880.00. Following the completion of the sale, the chief executive officer now directly owns 176,643 shares in the company, valued at $10,867,077.36. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, COO Christopher R. Armstrong sold 3,902 shares of Ceridian HCM stock in a transaction dated Thursday, February 9th. The stock was sold at an average price of $77.50, for a total transaction of $302,405.00. Following the sale, the chief operating officer now owns 96,575 shares of the company’s stock, valued at $7,484,562.50. The disclosure for this sale can be found here. In the last three months, insiders sold 22,902 shares of company stock worth $1,547,255. 4.00% of the stock is owned by corporate insiders.

Ceridian HCM Stock Down 2.6 %

Shares of NYSE CDAY opened at $72.92 on Monday. The company has a quick ratio of 1.07, a current ratio of 1.08 and a debt-to-equity ratio of 0.58. The firm has a 50-day moving average price of $69.34 and a 200 day moving average price of $64.72. Ceridian HCM Holding Inc. has a 52 week low of $43.23 and a 52 week high of $79.66. The stock has a market capitalization of $11.08 billion, a price-to-earnings ratio of -151.91 and a beta of 1.46.

About Ceridian HCM

(Get Rating)

Ceridian HCM Holding, Inc engages in the development of human capital management software. It offers Dayforce, Powerpay, and Bureau products and services. The Dayforce provides human resources (HR), payroll, benefits, workforce management, and talent management functionality. Powerpay is a cloud HR and payroll solution for the Canadian small business market, through both direct sales and established partner channels.

See Also

Institutional Ownership by Quarter for Ceridian HCM (NYSE:CDAY)

Receive News & Ratings for Ceridian HCM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceridian HCM and related companies with MarketBeat.com's FREE daily email newsletter.